腹腔大动脉动脉瘤透析患者的风险因素和死亡率:一项回顾性队列研究
Gabriela Duchesne1, Di Xia1, Jennifer L Waller2
1Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA.
概括
腹腔大动脉瘤 (AAA) 在末期脏疾病 (ESRD) 患者中很常见. 这项研究发现,AAA在调整其他因素后,不会增加ESRD患者的死亡风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 血管外科 血管外科
- 流行病学 流行病学
背景情况:
- 腹腔大动脉动脉瘤 (AAA) 是一般人群死亡的重要原因.
- 血管疾病在末期病 (ESRD) 患者中普遍存在,但AAA的流行率和影响在这个群体中未得到充分研究.
研究的目的:
- 在末期脏病 (ESRD) 患者中调查腹腔大动脉瘤 (AAA) 诊断的风险因素.
- 确定腹腔大动脉动脉瘤 (AAA) 与透析患者的死亡风险之间的关联.
主要方法:
- 利用美国脏数据系统 (USRDS) 来识别2005-2014年间发生的透析患者.
- 采用Cox比例危险 (CPH) 建模来分析死亡风险,根据人口统计和临床相关疾病进行调整.
- 从820,826名ESRD患者的队列中,确定了21,631名AAA患者.
主要成果:
- AAA患者年龄较大,更有可能是白人男性,并具有较高的并发病率,高血压和烟草使用.
- 最初的分析表明AAA患者的死亡风险增加.
- 经过调整以考虑混因素,特别是年龄,AAA与死亡风险降低有关 (aHR=0.83,95% CI 0.81-0.84).
结论:
- 腹腔大动脉瘤 (AAA) 并没有独立地与末期脏病 (ESRD) 患者的死亡率增加有关.
- 在评估ESRD患者的AAA和死亡率时,年龄是显著的混因素.
- 进一步的研究应该探索在这个脆弱人群中AAA的具体机制和管理.
相关概念视频
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...


